Alastair Garfield, the Chief Scientific Officer of $RYTM, sold 1,313 shares of the company on 07-02-2025 for an estimated $85,095. We received data on the trade from a recent SEC filing. This was a sale of approximately 29.5% of their shares of this class of stock. Following this trade, they now own 3,132 shares of this class of $RYTM stock.
$RYTM Insider Trading Activity
$RYTM insiders have traded $RYTM stock on the open market 51 times in the past 6 months. Of those trades, 0 have been purchases and 51 have been sales.
Here’s a breakdown of recent trading of $RYTM stock by insiders over the last 6 months:
- YANN MAZABRAUD (EVP, Head of International) has made 0 purchases and 5 sales selling 99,495 shares for an estimated $5,382,716.
- DAVID W J MCGIRR has made 0 purchases and 2 sales selling 65,431 shares for an estimated $4,267,494.
- DAVID P MEEKER (President and CEO) has made 0 purchases and 4 sales selling 57,794 shares for an estimated $3,657,824.
- PAMELA J. CRAMER (Chief Human Resources Officer) has made 0 purchases and 10 sales selling 37,407 shares for an estimated $2,334,699.
- JENNIFER KAYDEN LEE (EVP, Head of North America) has made 0 purchases and 13 sales selling 14,784 shares for an estimated $866,161.
- HUNTER C SMITH (Chief Financial Officer) has made 0 purchases and 6 sales selling 5,940 shares for an estimated $343,345.
- JOSEPH SHULMAN (Chief Technical Officer) has made 0 purchases and 6 sales selling 3,772 shares for an estimated $218,510.
- CHRISTOPHER PAUL GERMAN (Corporate Controller & CAO) has made 0 purchases and 3 sales selling 3,048 shares for an estimated $194,005.
- ALASTAIR GARFIELD (Chief Scientific Officer) has made 0 purchases and 2 sales selling 1,319 shares for an estimated $85,483.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$RYTM Hedge Fund Activity
We have seen 127 institutional investors add shares of $RYTM stock to their portfolio, and 84 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 1,575,266 shares (+1392.7%) to their portfolio in Q1 2025, for an estimated $83,441,840
- WESTFIELD CAPITAL MANAGEMENT CO LP added 1,341,092 shares (+inf%) to their portfolio in Q1 2025, for an estimated $71,037,643
- FRAZIER LIFE SCIENCES MANAGEMENT, L.P. removed 1,191,048 shares (-63.7%) from their portfolio in Q1 2025, for an estimated $63,089,812
- PERCEPTIVE ADVISORS LLC removed 1,132,028 shares (-30.8%) from their portfolio in Q1 2025, for an estimated $59,963,523
- POLAR CAPITAL HOLDINGS PLC removed 1,000,000 shares (-66.7%) from their portfolio in Q1 2025, for an estimated $52,970,000
- PRIMECAP MANAGEMENT CO/CA/ removed 783,868 shares (-11.9%) from their portfolio in Q1 2025, for an estimated $41,521,487
- PRICE T ROWE ASSOCIATES INC /MD/ added 513,901 shares (+75.0%) to their portfolio in Q1 2025, for an estimated $27,221,335
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$RYTM Analyst Ratings
Wall Street analysts have issued reports on $RYTM in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 03/18/2025
To track analyst ratings and price targets for $RYTM, check out Quiver Quantitative's $RYTM forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
